Changes in blood metabolomes as potential biomarkers for severity and prognosis in doxorubicin-induced heart failure: a study in HER2-positive and HER2-negative breast cancer patients
2 September 2024 (08:45 - 08:55)
Organised by: 
About the speaker
Chiang Mai University, Chiang Mai (Thailand)
5 More presentations in this session
Associate Professor A. Frustaci (Rome, IT)
Doctor D. Nelson (Melbourne, AU)
Mr E. Zulfaj (Gothenburg, SE)
Professor A. Barac (Fairfax, US)
Access the full session
The Event
ESC Congress 2024
2 September 2024
08:45 CET
You may be interested in
Congress Session
Congress Presentation
